New study reveals novel insights into the role of blood vessels within the tumour microenvironment in the regulation of cancer growth. Understanding this relationship better may provide new avenues that can be explored for cancer therapies.
An immunotherapy drug called ‘avelumab’ has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial led by Professor Tom Powles.
The tumour microenvironment: Key to controlling cancer cell growth Research led by Barts Cancer Institute (BCI), Queen Mary University of London, reveals novel insights into the role of the tumour microenvironment (TME) in the regulation of cancer growth. Gaining a more comprehensive understanding of the communication between cancer cells and their TME, and how these […]